These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 10587107)

  • 1. 99mTc-monoclonal antibody radiolabeled via hydrazino nicotinamide derivative for imaging disialoganglioside G(D2)-positive tumors.
    Fonti R; Cheung NK; Bridger GJ; Guo HF; Abrams MJ; Larson SM
    Nucl Med Biol; 1999 Aug; 26(6):681-6. PubMed ID: 10587107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radioimmunodetection of neuroblastoma with iodine-131-3F8: correlation with biopsy, iodine-131-metaiodobenzylguanidine and standard diagnostic modalities.
    Yeh SD; Larson SM; Burch L; Kushner BH; Laquaglia M; Finn R; Cheung NK
    J Nucl Med; 1991 May; 32(5):769-76. PubMed ID: 1902508
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complete tumor ablation with iodine 131-radiolabeled disialoganglioside GD2-specific monoclonal antibody against human neuroblastoma xenografted in nude mice.
    Cheung NK; Landmeier B; Neely J; Nelson AD; Abramowsky C; Ellery S; Adams RB; Miraldi F
    J Natl Cancer Inst; 1986 Sep; 77(3):739-45. PubMed ID: 3091900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Localization of GD2-specific monoclonal antibody 3F8 in human osteosarcoma.
    Heiner JP; Miraldi F; Kallick S; Makley J; Neely J; Smith-Mensah WH; Cheung NK
    Cancer Res; 1987 Oct; 47(20):5377-81. PubMed ID: 3115567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the targeting characteristics of various radioimmunoconjugates for radioimmunotherapy of neuroblastoma: dosimetry calculations incorporating cross-organ beta doses.
    Ugur O; Kostakoglu L; Hui ET; Fisher DR; Garmestani K; Gansow OA; Cheung NK; Larson SM
    Nucl Med Biol; 1996 Jan; 23(1):1-8. PubMed ID: 9004907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting of ganglioside GD2 monoclonal antibody to neuroblastoma.
    Cheung NK; Neely JE; Landmeier B; Nelson D; Miraldi F
    J Nucl Med; 1987 Oct; 28(10):1577-83. PubMed ID: 3655911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intrathecal administration of an anti-ganglioside antibody results in specific accumulation within meningeal neoplastic xenografts in nude rats.
    Bergman I; Pohl CR; Venkataramanan R; Burckart GJ; Stabin M; Barmada MA; Griffin JA; Cheung NK
    J Immunother; 1999 Mar; 22(2):114-23. PubMed ID: 10093036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiolabeled humanized anti-CD3 monoclonal antibody visilizumab for imaging human T-lymphocytes.
    Malviya G; D'Alessandria C; Bonanno E; Vexler V; Massari R; Trotta C; Scopinaro F; Dierckx R; Signore A
    J Nucl Med; 2009 Oct; 50(10):1683-91. PubMed ID: 19759100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative studies of monoclonal antibody targeting to disialoganglioside GD2 in human brain tumors.
    Arbit E; Cheung NK; Yeh SD; Daghighian F; Zhang JJ; Cordon-Cardo C; Pentlow K; Canete A; Finn R; Larson SM
    Eur J Nucl Med; 1995 May; 22(5):419-26. PubMed ID: 7641750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase I study of targeted radioimmunotherapy for leptomeningeal cancers using intra-Ommaya 131-I-3F8.
    Kramer K; Humm JL; Souweidane MM; Zanzonico PB; Dunkel IJ; Gerald WL; Khakoo Y; Yeh SD; Yeung HW; Finn RD; Wolden SL; Larson SM; Cheung NK
    J Clin Oncol; 2007 Dec; 25(34):5465-70. PubMed ID: 18048828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Specific localization, gamma camera imaging, and intracellular trafficking of radiolabelled chimeric anti-G(D3) ganglioside monoclonal antibody KM871 in SK-MEL-28 melanoma xenografts.
    Lee FT; Rigopoulos A; Hall C; Clarke K; Cody SH; Smyth FE; Liu Z; Brechbiel MW; Hanai N; Nice EC; Catimel B; Burgess AW; Welt S; Ritter G; Old LJ; Scott AM
    Cancer Res; 2001 Jun; 61(11):4474-82. PubMed ID: 11389078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of neuroblastoma meningeal carcinomatosis with intrathecal application of alpha-emitting atomic nanogenerators targeting disialo-ganglioside GD2.
    Miederer M; McDevitt MR; Borchardt P; Bergman I; Kramer K; Cheung NK; Scheinberg DA
    Clin Cancer Res; 2004 Oct; 10(20):6985-92. PubMed ID: 15501978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the biodistribution and the efficacy of monoclonal antibody 323/A3 labeled with either 131I or 186Re in human ovarian cancer xenografts.
    Kievit E; van Gog FB; Schlüper HM; van Dongen GA; Pinedo HM; Boven E
    Int J Radiat Oncol Biol Phys; 1997 Jul; 38(4):813-23. PubMed ID: 9240651
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calculated and TLD-based absorbed dose estimates for I-131-labeled 3F8 monoclonal antibody in a human neuroblastoma xenograft nude mouse model.
    Ugur O; Scott AM; Kostakoglu L; Hui TE; Masterson ME; Febo R; Sgouros G; Rosa E; Mehta BM; Fisher DR
    Nucl Med Biol; 1995 Jan; 22(1):87-93. PubMed ID: 7735175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of cleavable and noncleavable hydrazinopyridine linkers for the 99mTc labeling of Fab' monoclonal antibody fragments.
    Bridger GJ; Abrams MJ; Padmanabhan S; Gaul F; Larsen S; Henson GW; Schwartz DA; Longley CB; Burton CA; Ultee ME
    Bioconjug Chem; 1996; 7(2):255-64. PubMed ID: 8983348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of spinal epidural neuroblastoma xenografts in rats using anti-GD2 monoclonal antibody 3F8.
    Bergman I; Arbit E; Rosenblum M; Larson SM; Heller G; Cheung NK
    J Neurooncol; 1993 Mar; 15(3):235-42. PubMed ID: 8360709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SPECT imaging of neuropilin receptor type-1 expression with 131I-labeled monoclonal antibody.
    Dou X; Yan J; Zhang Y; Liu P; Jiang Y; Lv S; Zeng F; Chen X; Wang S; Zhang H; Wu H; Zhang H; Ouyang L; Su X
    Int J Oncol; 2016 Sep; 49(3):961-70. PubMed ID: 27315007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SPECT imaging of colorectal cancer by targeting CD 133 receptor with 99mTc-labeled monoclonal antibody.
    Liu Y; Jin X; Lan X; Lang J; Wen Q; An R
    Q J Nucl Med Mol Imaging; 2019 Jun; 63(2):216-224. PubMed ID: 27387378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo and in vitro characterizations of three 99mTc-labeled monoclonal antibody G250 preparations.
    Steffens MG; Oosterwijk E; Kranenborg MH; Manders JM; Debruyne FM; Corstens FH; Boerman OC
    J Nucl Med; 1999 May; 40(5):829-36. PubMed ID: 10319758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preparation of hydrazino-modified proteins and their use for the synthesis of 99mTc-protein conjugates.
    Schwartz DA; Abrams MJ; Hauser MM; Gaul FE; Larsen SK; Rauh D; Zubieta JA
    Bioconjug Chem; 1991; 2(5):333-6. PubMed ID: 1838699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.